Institutional Ownership Avidity Biosciences, Inc. (RNA)
This table provides information about the institutional ownership of Avidity Biosciences, Inc. (RNA). We have compiled data on the 231 institutions that hold shares in the stock, with a total of 119 Million shares, which have been reported (via 13F filing form) to have a value of $5.51 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
10,808,727
shares
|
$500 Million
0.03% of portfolio
|
Q2 2025
Reduced 4.67%
|
|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
10,777,317
shares
|
$498 Million
0.16% of portfolio
|
Q2 2025
Reduced 5.68%
|
|
Rtw Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
9,618,845
shares
|
$445 Million
4.2% of portfolio
|
Q2 2025
Added 9.97%
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
9,249,690
shares
|
$428 Million
0.05% of portfolio
|
Q2 2025
Reduced 4.49%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
9,248,302
shares
|
$428 Million
0.0% of portfolio
|
Q2 2025
Added 0.06%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
8,622,513
shares
|
$399 Million
0.01% of portfolio
|
Q2 2024
Added 39.84%
|
|
Ra Capital Management, L.P.
Boston, MA |
Aug 14, 2025 Q2 2025 |
7,266,031
shares
|
$336 Million
4.51% of portfolio
|
Q2 2025
Added 15.33%
|
|
Avoro Capital Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
7,050,000
shares
|
$326 Million
3.65% of portfolio
|
Q2 2025
Reduced 7.54%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
4,201,509
shares
|
$194 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.77%
|
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
Aug 14, 2025 Q2 2025 |
3,532,825
shares
|
$163 Million
0.17% of portfolio
|
Q2 2025
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,847,965
shares
|
$132 Million
0.01% of portfolio
|
Q2 2025
Added 3.37%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
1,839,315
shares
|
$85 Million
0.0% of portfolio
|
Q2 2025
Added 16.82%
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
1,812,886
shares
|
$83.8 Million
1.84% of portfolio
|
Q1 2025
Added 62.9%
|
|
Casdin Capital, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
1,775,000
shares
|
$82.1 Million
7.07% of portfolio
|
Q2 2025
Reduced 13.2%
|
|
Polar Capital Holdings PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
1,770,387
shares
|
$81.8 Million
0.29% of portfolio
|
Q2 2025
Reduced 1.03%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,527,000
shares
|
$70.6 Million
0.08% of portfolio
|
Q2 2025
Reduced 28.84%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,145,534
shares
|
$53 Million
0.0% of portfolio
|
Q2 2025
Added 45.98%
|
|
Siren, L.L.C.
New York, NY |
Aug 13, 2025 Q2 2025 |
1,110,610
shares
|
$51.3 Million
1.63% of portfolio
|
Q1 2025
Reduced 1.48%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
1,048,219
shares
|
$48.5 Million
0.01% of portfolio
|
Q2 2025
Added 2.41%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
997,055
shares
|
$46.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.1%
|
|
Norges Bank
Oslo, Q8 |
Aug 13, 2025 Q2 2025 |
995,118
shares
|
$46 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Aug 13, 2025 Q2 2025 |
967,602
shares
|
$44.7 Million
0.03% of portfolio
|
Q2 2025
Added 10.81%
|
|
Logos Global Management LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
950,000
shares
|
$43.9 Million
3.48% of portfolio
|
Q2 2025
Added 171.43%
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
May 14, 2025 Q1 2025 |
928,227
shares
|
$42.9 Million
0.05% of portfolio
|
Q1 2025
Reduced 8.57%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
813,905
shares
|
$37.6 Million
0.01% of portfolio
|
Q2 2025
Added 5.54%
|